Insider Transactions in Q3 2024 at Agile Therapeutics Inc (AGRX)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 26
2024
|
Geoffrey Gilmore Chief Administrative Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,256
-74.99%
|
$20,256
$1.52 P/Share
|
|
Aug 26
2024
|
Amy Welsh Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,500
-87.5%
|
$13,500
$1.52 P/Share
|
|
Aug 26
2024
|
Paul Korner Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,500
-87.5%
|
$13,500
$1.52 P/Share
|
|
Aug 26
2024
|
Robert G Conway Chief Supply Chain Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,529
-87.42%
|
$13,529
$1.52 P/Share
|
|
Aug 26
2024
|
Scott M Coiante Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,080
-87.35%
|
$20,080
$1.52 P/Share
|
|
Aug 26
2024
|
Sharon Barbari Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
973
-100.0%
|
$973
$1.52 P/Share
|
|
Aug 26
2024
|
Josephine Torrente Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
987
-50.66%
|
$987
$1.52 P/Share
|
|
Aug 26
2024
|
John W Hubbard Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
976
-100.0%
|
$976
$1.52 P/Share
|
|
Aug 26
2024
|
Seth H. Z. Fischer Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
976
-100.0%
|
$976
$1.52 P/Share
|
|
Aug 26
2024
|
Alfred Altomari Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
47,749
-79.45%
|
$47,749
$1.52 P/Share
|
|
Aug 26
2024
|
Sandra Carson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
973
-100.0%
|
$973
$1.52 P/Share
|